FUTURE DIRECTIONS IN RESEARCH
The use of monoclonal antibodies, especially “humanized” ones, will play an increasingly important role in both basic immunology and clinical immunology. Their use will be in both detection of small and early tumours and in the treatment of tumors. The success of monoclonal antibodies in metastatic prostate cancer is already well established. It is believed that other tumour therapies will follow in the future.